Virtual Screening and Biological Evaluation of Potential PD-1/PD-L1 Immune Checkpoint Inhibitors as Anti-Hepatocellular Carcinoma Agents

[Image: see text] Blockade of the programmed cell death-1/programmed cell death ligand-1 (PD-1/PD-L1) immune checkpoint pathway is an efficient immunotherapeutic modality that provided significant advances in cancer treatment especially in solid tumors highly resistant to traditional therapy. Monocl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamal, Monica A., Badary, Hedy A., Omran, Dalia, Shousha, Hend I., Abdelaziz, Ashraf O., El Tayebi, Hend M., Mandour, Yasmine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515376/
https://www.ncbi.nlm.nih.gov/pubmed/37744828
http://dx.doi.org/10.1021/acsomega.3c00279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515376/
https://www.ncbi.nlm.nih.gov/pubmed/37744828
http://dx.doi.org/10.1021/acsomega.3c00279

Ejemplares similares